Cell therapy weekly: license granted for the manufacture and supply of synthetic DNA

by admin | Apr 21, 2025 | News & Opinions

by Kadeja Johnson – RegMedNet – 4basebio PLC has received a Good Manufacturing Practice certification from the UK Medicine and Healthcare Regulatory Agency (London), authorizing the company to supply GMP-grade synthetic DNA as both a starting material and...

Japan’s big bet on stem-cell therapies might soon pay off with medical breakthroughs

by admin | Apr 18, 2025 | News & Opinions

By Smriti Mallapaty – Nature – Induced pluripotent stem cells are being tested to treat blindness, paralysis, Parkinson’s disease and more. Approvals might be around the corner. Japan is brimming with signs of an approaching medical revolution. Shiny white robots are...

US risks losing biotech edge to China, report warns

by admin | Apr 17, 2025 | News & Opinions

By Ned Pagliarulo – PharmaVoice – A commission urged the U.S. government to prioritize biotechnology funding and policies to stay ahead of China in fields it argued are vital to national security. The U.S. risks losing a once-decisive edge over China in...

The Global Synthetic Biology Conference: San Jose, California | May 5-8, 2025

by admin | Apr 15, 2025 | News & Opinions

This is where the world’s top innovators, thought leaders, entrepreneurs, and investors come together to build a better world with synthetic biology. Join us in San Jose as we explore how synbio is transforming industries from healthcare, agriculture,...

The Expert Who Kept Eye Drops From Blinding You Was Fired Yesterday

by admin | Apr 14, 2025 | News & Opinions

By Katherine Eban – Vanity Fair – If you’ve ever used eye drops that didn’t blind you, thank Dr. Timothy J. Pohlhaus. As of yesterday, he’s gone. And if you’ve ever been injected with a sterile drug that helped heal you instead of killing you, you have...